{"name": "Oncopeptides",
 "permalink": "oncopeptides",
 "crunchbase_url": "http://www.crunchbase.com/company/oncopeptides",
 "homepage_url": "http://www.oncopeptides.se",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "46-(0)-705-695-471",
 "description": "",
 "created_at": "Sat Oct 22 06:50:47 UTC 2011",
 "updated_at": "Wed May 22 03:05:52 UTC 2013",
 "overview": "\u003Cp\u003EOncopeptides AB is a privately held company developing pharmaceuticals to treat cancer. The Company has developed proprietary technology based on creating pro-drugs with increased efficacy of already known and effective cytotoxic compounds. The lead substance, called J1 (melphalan flufenamide) is presently in a phase I/II clinical trial and is currently seeking co-development/licensing partners for the major geographical regions. Oncopeptides is a portfolio company of Karolinska Development AB publ and Stiftelsen Industrifonden.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0015/9110/159110v1-max-150x150.jpg"],
     [[228,
       53],
      "assets/images/resized/0015/9110/159110v1-max-250x250.jpg"],
     [[228,
       53],
      "assets/images/resized/0015/9110/159110v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jakob",
      "last_name": "Lindberg",
      "permalink": "jakob-lindberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130521e95lr56ti\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130521e95lr56ti%26from%3dalert%26pid%3d32",
    "source_description": "Oncopeptides Completes Series A for Multiple Myeloma Clinical Trial ",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 21,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}